Trials / Completed
CompletedNCT05819502
"Profile HIT" (Holistic Individualized Treatment)
A Prospective Clinical Trial Evaluating the "Profile HIT" (Holistic Individualized Treatment)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Erevna Innovations Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The "Holistic Individualized Treatment" (HIT) approach is used to identify treatment priorities, focus areas, and appropriate products for soft tissue filler treatments. The "Profile HIT" considers the balance between the midface, nose, lips, and chin to improve a patient's appearance. This trial will assess the effectiveness of the Profile HIT algorithm in treating patients with different profile issues (e.g. nasal deformities, volume loss, chin retrusion).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Restylane line of injectables | Restylane fillers are manufactured by Q-Med AB, part of the Galderma Group. |
Timeline
- Start date
- 2023-03-20
- Primary completion
- 2024-02-24
- Completion
- 2024-03-24
- First posted
- 2023-04-19
- Last updated
- 2025-02-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05819502. Inclusion in this directory is not an endorsement.